Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,458
Closed -$758K 557
2023
Q3
$758K Sell
1,458
-6,069
-81% -$3.16M 0.1% 347
2023
Q2
$4.08M Sell
7,527
-22
-0.3% -$12K 0.56% 31
2023
Q1
$4.06M Buy
7,549
+2,150
+40% +$1.1M 0.55% 16
2022
Q4
$2.76M Buy
5,399
+3,151
+140% +$1.53M 0.45% 38
2022
Q3
$981K Buy
+2,248
New +$1.08M 0.15% 223
2021
Q2
Sell
-1,112
Closed -$511K 816
2021
Q1
$511K Buy
+1,112
New +$545K 0.04% 503
2017
Q1
Sell
-5,876
Closed -$943K 478
2016
Q4
$943K Sell
5,876
-7,224
-55% -$1.06M 0.06% 340
2016
Q3
$1.85M Hold
13,100
0.11% 235
2016
Q2
$1.79M Hold
13,100
0.14% 206
2016
Q1
$1.77M Sell
13,100
-5,057
-28% -$684K 0.11% 248
2015
Q4
$2.72M Buy
18,157
+4,857
+37% +$718K 0.37% 124
2015
Q3
$1.77M Buy
13,300
+200
+2% +$28K 0.04% 501
2015
Q2
$1.72M Hold
13,100
0.04% 484
2015
Q1
$1.56M Buy
+13,100
New +$1.45M 0.04% 540
2014
Q4
Sell
-16,908
Closed -$1.74M 693
2014
Q3
$1.74M Buy
16,908
+14,231
+532% +$1.44M 0.04% 463
2014
Q2
$251K Sell
2,677
-43,581
-94% -$3.86M 0.01% 1253
2014
Q1
$4.14M Buy
+46,258
New +$3.77M 0.1% 255
2013
Q4
Sell
-8,709
Closed -$623K 705
2013
Q3
$623K Buy
8,709
+1,434
+20% +$102K 0.02% 965
2013
Q2
$527K Buy
+7,275
New +$534K 0.01% 1038

Other funds holding CHE

PDT Partners's CHE Position: Q4 2023 in Review

PDT Partners sold out of Chemed (CHE) in Q4 2023, closing a stake of 1,458 shares — an estimated $758K sold.

PDT Partners first reported a position in CHE in Q2 2013 and held it in 19 quarters. The position peaked at $4.14M in Q1 2014. 501 funds tracked by Wall St. Rank hold CHE as of Q4 2023.

  • PDT Partners reported no remaining Chemed position as of Q4 2023 after selling out during the quarter.
  • PDT Partners sold 1,458 Chemed shares in Q4 2023, an estimated $758K.
  • PDT Partners first reported a position in Chemed in Q2 2013 and held it in 19 quarters.
  • PDT Partners's Chemed position peaked at $4.14M in Q1 2014.
  • 501 funds tracked by Wall St. Rank held Chemed as of Q4 2023.

Based on PDT Partners's 13F filing for Q4 2023, filed 14 Feb 2024.